Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1279

1.

Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.

Malaeb BS, Rashid HH, Lotan Y, Khoddami SM, Shariat SF, Sagalowsky AI, McConnell JD, Roehrborn CG, Koeneman KS.

Urol Oncol. 2007 Jul-Aug;25(4):291-7.

PMID:
17628294
2.

Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.

Khan MA, Han M, Partin AW, Epstein JI, Walsh PC.

Urology. 2003 Jul;62(1):86-91; discussion 91-2.

PMID:
12837428
4.

Impact of patient age on biochemical recurrence rates following radical prostatectomy.

Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML.

J Urol. 2007 Nov;178(5):1933-7; discussion 1937-8. Epub 2007 Sep 17.

PMID:
17868723
5.

Familial prostate cancer: a different disease?

Kupelian PA, Klein EA, Witte JS, Kupelian VA, Suh JH.

J Urol. 1997 Dec;158(6):2197-201.

PMID:
9366343
6.

Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer.

Khan MA, Partin AW, Mangold LA, Epstein JI, Walsh PC.

Urology. 2003 Nov;62(5):866-71.

PMID:
14624910
7.

The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.

DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML.

J Urol. 2005 Apr;173(4):1121-5.

PMID:
15758719
8.

After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.

Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H.

BJU Int. 2008 Jan;101(2):170-4. doi: 10.1111/j.1464-410X.2007.07270.x.

9.

Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: a tool to facilitate treatment decisions.

Nelson CP, Dunn RL, Wei JT, Rubin MA, Montie JE, Sanda MG.

Urol Oncol. 2003 May-Jun;21(3):213-8.

PMID:
12810209
10.

Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.

Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane CJ, Amling CL, Presti JC Jr, Mangold LA, Humphreys E, Epstein JI, Partin AW, Freedland SJ.

Cancer. 2006 Sep 15;107(6):1265-72.

11.

Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.

Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.

J Urol. 2005 Dec;174(6):2181-5.

PMID:
16280760
12.

Do younger men have better biochemical outcomes after radical prostatectomy?

Freedland SJ, Presti JC Jr, Kane CJ, Aronson WJ, Terris MK, Dorey F, Amling CL; SEARCH Database Study Group.

Urology. 2004 Mar;63(3):518-22.

PMID:
15028449
13.

Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors.

Bloom KD, Richie JP, Schultz D, Renshaw A, Saegaert T, D'amico AV.

Urology. 2004 Feb;63(2):333-6.

PMID:
14972484
14.

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.

J Urol. 2003 Feb;169(2):517-23.

PMID:
12544300
15.

Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.

Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK.

Urology. 2004 Jul;64(1):84-9.

PMID:
15245941
16.

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.

Pound CR, Partin AW, Epstein JI, Walsh PC.

Urol Clin North Am. 1997 May;24(2):395-406.

PMID:
9126237
17.

Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?

Barocas DA, Han M, Epstein JI, Chan DY, Trock BJ, Walsh PC, Partin AW.

Urology. 2001 Nov;58(5):746-51.

PMID:
11711353
18.

Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.

Salomon L, Anastasiadis AG, Johnson CW, McKiernan JM, Goluboff ET, Abbou CC, Olsson CA, Benson MC.

Urology. 2003 Aug;62(2):304-9.

PMID:
12893340
19.

Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.

Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ.

Urology. 2004 Oct;64(4):723-8.

PMID:
15491709
20.

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

Han M, Partin AW, Pound CR, Epstein JI, Walsh PC.

Urol Clin North Am. 2001 Aug;28(3):555-65. Review.

PMID:
11590814

Supplemental Content

Support Center